Goat adverse-event record

Goat Adverse Event Insights

The FDA Center for Veterinary Medicine database holds 435 adverse event reports for Goat, distributed across 9 distinct breeds currently tracked in the system. Of those reports, 179 involved a death outcome, producing a 41.1% case-fatality rate among reported events, which reflects reporting severity bias rather than true population mortality. These figures are aggregated directly from openFDA's Animal & Veterinary Adverse Events endpoint and update as new voluntary submissions flow through pet owners, veterinarians, and drug manufacturers.

The most frequently reported clinical signs for Goat are Death (151 reports), Lack of efficacy - NOS (39 reports), Diarrhoea (32 reports), No sign (27 reports), with Death leading the reaction traffic at 151 submissions. On the product side, Moxidectin is the single most-referenced drug with 49 reports, followed by Monensin Sodium (42), Albendazole (31), Fenbendazol Suspension (29). This combination surfaces which therapeutic classes generate the most adverse event chatter for this species, a useful starting point when comparing Goat reporting patterns against other companion animals in the dataset.

Of the 431 Goat reports with a coded outcome, Died accounts for the largest share at 39.2%. Annual submission volume spans 18 to 38 reports across the 16 years on file, a range that reflects evolving owner awareness, veterinary reporting habits, and new product approvals rather than stable underlying incidence. The breed-level table below breaks these patterns down further, showing how the 9 tracked goat breeds compare on volume, deaths, and average age at report. As with all FDA adverse event data, correlation is the ceiling, causation requires clinical investigation beyond what these aggregates can provide.